Kouta Funakoshi

965 total citations
41 papers, 613 citations indexed

About

Kouta Funakoshi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Kouta Funakoshi has authored 41 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Kouta Funakoshi's work include Heart Failure Treatment and Management (11 papers), Cardiovascular Function and Risk Factors (7 papers) and Coronary Interventions and Diagnostics (6 papers). Kouta Funakoshi is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Cardiovascular Function and Risk Factors (7 papers) and Coronary Interventions and Diagnostics (6 papers). Kouta Funakoshi collaborates with scholars based in Japan, China and United States. Kouta Funakoshi's co-authors include Kenji Sunagawa, Kaku Nakano, Kensuke Egashira, Tomomi Ide, Gang Zhao, Hiroyuki Tsutsui, Kisho Ohtani, Ryuji Tominaga, Nobuyuki Enzan and Takeshi Tohyama and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Kouta Funakoshi

38 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kouta Funakoshi Japan 13 290 179 88 87 87 41 613
Kazuhiro Nagaoka Japan 10 177 0.6× 108 0.6× 124 1.4× 72 0.8× 74 0.9× 24 517
Brett G. Zani United States 13 169 0.6× 257 1.4× 70 0.8× 46 0.5× 157 1.8× 24 538
Won‐Woo Seo South Korea 15 229 0.8× 225 1.3× 80 0.9× 49 0.6× 117 1.3× 46 585
Н. Ш. Загидуллин Russia 12 193 0.7× 133 0.7× 275 3.1× 35 0.4× 44 0.5× 95 631
Yosuke Murase Japan 16 464 1.6× 241 1.3× 172 2.0× 141 1.6× 69 0.8× 35 963
Yanping Cheng United States 14 173 0.6× 309 1.7× 177 2.0× 51 0.6× 154 1.8× 57 676
Colin Stirrat United Kingdom 12 219 0.8× 120 0.7× 55 0.6× 30 0.3× 72 0.8× 24 492
Nadia Salerno Italy 12 145 0.5× 136 0.8× 139 1.6× 25 0.3× 42 0.5× 36 454
Chi-Ming Huang Taiwan 12 199 0.7× 148 0.8× 83 0.9× 26 0.3× 52 0.6× 17 576
Jason M. Duran United States 16 337 1.2× 189 1.1× 411 4.7× 57 0.7× 52 0.6× 31 877

Countries citing papers authored by Kouta Funakoshi

Since Specialization
Citations

This map shows the geographic impact of Kouta Funakoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kouta Funakoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kouta Funakoshi more than expected).

Fields of papers citing papers by Kouta Funakoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kouta Funakoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kouta Funakoshi. The network helps show where Kouta Funakoshi may publish in the future.

Co-authorship network of co-authors of Kouta Funakoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kouta Funakoshi. A scholar is included among the top collaborators of Kouta Funakoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kouta Funakoshi. Kouta Funakoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanegashima, Tokiyoshi, et al.. (2025). Biology and evolving management of resectable dMMR/MSI-H cancers: current status and future perspectives. Cancer Immunology Immunotherapy. 74(12). 364–364.
2.
Nakamura, Katsumasa, Keiji Nihei, Yoshihiro Saito, et al.. (2024). A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer. International Journal of Clinical Oncology. 29(6). 847–852. 5 indexed citations
3.
Amitani, Haruka, Kouta Funakoshi, Hiroko Watanabe, et al.. (2023). The effect of lavender aroma for anxiety disorder: a study protocol for a multicenter, double-masked, randomized, placebo-controlled clinical trial. BMC Complementary Medicine and Therapies. 23(1). 397–397. 2 indexed citations
4.
Shinohara, Keisuke, Nobuyuki Enzan, Shouji Matsushima, et al.. (2023). A higher resting heart rate is associated with cardiovascular event risk in patients with type 2 diabetes mellitus without known cardiovascular disease. Hypertension Research. 46(5). 1090–1099. 9 indexed citations
6.
Enzan, Nobuyuki, Shouji Matsushima, Tomomi Ide, et al.. (2022). The Use of Angiotensin II Receptor Blocker is Associated with Greater Recovery of Cardiac Function than Angiotensin-Converting Enzyme Inhibitor in Dilated Cardiomyopathy. ESC Heart Failure. 9(2). 1175–1185. 8 indexed citations
7.
Amitani, Marie, Haruka Amitani, Tetsuhiro Owaki, et al.. (2022). The Effect of Mindfulness Yoga in Children With School Refusal: A Study Protocol for an Exploratory, Cluster-Randomized, Open, Standard Care-Controlled, Multicenter Clinical Trial. Frontiers in Public Health. 10. 881303–881303. 5 indexed citations
8.
Shinohara, Keisuke, Nobuyuki Enzan, Shouji Matsushima, et al.. (2022). Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease. International Journal of Cardiology. 356. 98–104. 3 indexed citations
9.
Enzan, Nobuyuki, Shouji Matsushima, Tomomi Ide, et al.. (2021). Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fraction. SHILAP Revista de lepidopterología. 11. 100053–100053. 1 indexed citations
10.
Enzan, Nobuyuki, Shouji Matsushima, Tomomi Ide, et al.. (2021). Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan ― Report From a National Registry of Clinical Personal Records ―. Circulation Reports. 3(3). 142–152. 8 indexed citations
11.
Tohyama, Takeshi, Tomomi Ide, Masataka Ikeda, et al.. (2021). Machine Learning-Based Model for Predicting 1 Year Mortality of Hospitalized Patients with Heart Failure. ESC Heart Failure. 8(5). 4077–4085. 29 indexed citations
12.
Kainuma, Mosaburo, Kouta Funakoshi, Shinji Ouma, et al.. (2020). The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial. Medicine. 99(38). e22370–e22370. 1 indexed citations
13.
Tohyama, Takeshi, Kouta Funakoshi, Hidetaka Kaku, et al.. (2020). Artificial intelligence-based analysis of payment system data can predict one-year mortality of hospitalized patients with heart failure. European Heart Journal. 41(Supplement_2). 2 indexed citations
14.
Ohtani, Kisho, Takeo Fujino, Tomomi Ide, et al.. (2018). Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity. Clinical Research in Cardiology. 108(6). 600–611. 24 indexed citations
15.
Funakoshi, Kouta, Kazuya Hosokawa, Takuya Kishi, Tomomi Ide, & Kenji Sunagawa. (2013). Striking Volume Intolerance Is Induced by Mimicking Arterial Baroreflex Failure in Normal Left Ventricular Function. Journal of Cardiac Failure. 20(1). 53–59. 30 indexed citations
16.
Tomita, Hideharu, Toshiaki Kadokami, Natsumi Kawamura, et al.. (2013). Patient Factors against Stable Control of Warfarin Therapy for Japanese Non-valvular Atrial Fibrillation Patients. Thrombosis Research. 132(5). 537–542. 16 indexed citations
17.
Hosokawa, Kazuya, Kouta Funakoshi, Atsushi Tanaka, et al.. (2011). Artificial baroreflex system restores volume tolerance in the absence of native baroreflex. PubMed. 276. 697–699. 2 indexed citations
18.
Nakano, Kaku, Kouta Funakoshi, Gang Zhao, et al.. (2011). Imatinib Mesylate-Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries. Journal of Atherosclerosis and Thrombosis. 18(12). 1043–1053. 49 indexed citations
19.
Nakano, Kaku, Kensuke Egashira, Kouta Funakoshi, et al.. (2009). Formulation of Nanoparticle-Eluting Stents by a Cationic Electrodeposition Coating Technology. JACC: Cardiovascular Interventions. 2(4). 277–283. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026